Latest filing published 23 Apr 2026 for Lemaitre Vascular INC, €89k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joseph P. Pellegrino Jr. (finance chief) discloses dealings in Lemaitre Vascular Inc to SEC (Form 4). Between 25 July 2021 and 22 April 2026, the trades on record add up to 30 filings.
No open-market purchase appears, only 1 sale worth €147k. Outside the open market, there are 6 share grants and 23 option exercises.
The newest entry dates from 23 April 2026: an option exercise of €89k, in Lemaitre Vascular Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 30 declarations